Senior Director, Compliance – Europe

<br/> <!-- --> <!-- --> <!-- --> <div> <!-- --> <div> <br/> <div> Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. Our R&amp;D pipeline comprises RAS(ON) Inhibitors and RAS Companion Inhibitors designed to suppress oncogenic variants of RAS proteins and enable combination treatment strategies.<br/>As we prepare for the launch of new therapies and continued expansion ac…